Global Haemophilus Influenzae Type B Vaccine Market Growth 2025-2031
The global Haemophilus Influenzae Type B Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Haemophilus Influenzae Type B Vaccine Industry Forecast” looks at past sales and reviews total world Haemophilus Influenzae Type B Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Haemophilus Influenzae Type B Vaccine sales for 2025 through 2031. With Haemophilus Influenzae Type B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Haemophilus Influenzae Type B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Haemophilus Influenzae Type B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Haemophilus Influenzae Type B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Haemophilus Influenzae Type B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Haemophilus Influenzae Type B Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Haemophilus Influenzae Type B Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Influenzae Type B Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Haemophilus Influenzae Type B Vaccine market?
What factors are driving Haemophilus Influenzae Type B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Haemophilus Influenzae Type B Vaccine market opportunities vary by end market size?
How does Haemophilus Influenzae Type B Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Haemophilus Influenzae Type B Vaccine Industry Forecast” looks at past sales and reviews total world Haemophilus Influenzae Type B Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Haemophilus Influenzae Type B Vaccine sales for 2025 through 2031. With Haemophilus Influenzae Type B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Haemophilus Influenzae Type B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Haemophilus Influenzae Type B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Haemophilus Influenzae Type B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Haemophilus Influenzae Type B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Haemophilus Influenzae Type B Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Haemophilus Influenzae Type B Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Influenzae Type B Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liquid Monovalent HIB
- Liquid Combination HIB
- Lyophilized Monovalent HIB
- Lyophilized Combination HIB
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Merck
- Sanofi
- GlaxoSmithKline
- Takeda Pharmaceuticals Company
- Walvax Biotechnology
- Lanzhou Institute of Biologica
- Immunize BC
What is the 10-year outlook for the global Haemophilus Influenzae Type B Vaccine market?
What factors are driving Haemophilus Influenzae Type B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Haemophilus Influenzae Type B Vaccine market opportunities vary by end market size?
How does Haemophilus Influenzae Type B Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Haemophilus Influenzae Type B Vaccine Segment by Type
2.2.1 Liquid Monovalent HIB
2.2.2 Liquid Combination HIB
2.2.3 Lyophilized Monovalent HIB
2.2.4 Lyophilized Combination HIB
2.3 Haemophilus Influenzae Type B Vaccine Sales by Type
2.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2020-2025)
2.4 Haemophilus Influenzae Type B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Haemophilus Influenzae Type B Vaccine Sales by Application
2.5.1 Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Haemophilus Influenzae Type B Vaccine Breakdown Data by Company
3.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2025)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Company
3.4 Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Location Distribution
3.4.2 Players Haemophilus Influenzae Type B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Haemophilus Influenzae Type B Vaccine Sales Growth
4.4 APAC Haemophilus Influenzae Type B Vaccine Sales Growth
4.5 Europe Haemophilus Influenzae Type B Vaccine Sales Growth
4.6 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country
5.1.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
5.1.2 Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
5.2 Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
5.3 Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region
6.1.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2020-2025)
6.1.2 APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2020-2025)
6.2 APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
6.3 APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
7.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
7.3 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine by Country
8.1.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine
10.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
10.4 Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Haemophilus Influenzae Type B Vaccine Distributors
11.3 Haemophilus Influenzae Type B Vaccine Customer
12 WORLD FORECAST REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
12.1 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Forecast by Region (2026-2031)
12.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Haemophilus Influenzae Type B Vaccine Forecast by Type (2026-2031)
12.7 Global Haemophilus Influenzae Type B Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Takeda Pharmaceuticals Company
13.5.1 Takeda Pharmaceuticals Company Company Information
13.5.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Takeda Pharmaceuticals Company Main Business Overview
13.5.5 Takeda Pharmaceuticals Company Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Lanzhou Institute of Biologica
13.7.1 Lanzhou Institute of Biologica Company Information
13.7.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lanzhou Institute of Biologica Main Business Overview
13.7.5 Lanzhou Institute of Biologica Latest Developments
13.8 Immunize BC
13.8.1 Immunize BC Company Information
13.8.2 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Immunize BC Main Business Overview
13.8.5 Immunize BC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Haemophilus Influenzae Type B Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Haemophilus Influenzae Type B Vaccine Segment by Type
2.2.1 Liquid Monovalent HIB
2.2.2 Liquid Combination HIB
2.2.3 Lyophilized Monovalent HIB
2.2.4 Lyophilized Combination HIB
2.3 Haemophilus Influenzae Type B Vaccine Sales by Type
2.3.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2020-2025)
2.4 Haemophilus Influenzae Type B Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Haemophilus Influenzae Type B Vaccine Sales by Application
2.5.1 Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Haemophilus Influenzae Type B Vaccine Breakdown Data by Company
3.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2025)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Haemophilus Influenzae Type B Vaccine Sale Price by Company
3.4 Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Haemophilus Influenzae Type B Vaccine Product Location Distribution
3.4.2 Players Haemophilus Influenzae Type B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Haemophilus Influenzae Type B Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Haemophilus Influenzae Type B Vaccine Sales Growth
4.4 APAC Haemophilus Influenzae Type B Vaccine Sales Growth
4.5 Europe Haemophilus Influenzae Type B Vaccine Sales Growth
4.6 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country
5.1.1 Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
5.1.2 Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
5.2 Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
5.3 Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region
6.1.1 APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2020-2025)
6.1.2 APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2020-2025)
6.2 APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
6.3 APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Haemophilus Influenzae Type B Vaccine by Country
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
7.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
7.3 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine by Country
8.1.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine
10.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
10.4 Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Haemophilus Influenzae Type B Vaccine Distributors
11.3 Haemophilus Influenzae Type B Vaccine Customer
12 WORLD FORECAST REVIEW FOR HAEMOPHILUS INFLUENZAE TYPE B VACCINE BY GEOGRAPHIC REGION
12.1 Global Haemophilus Influenzae Type B Vaccine Market Size Forecast by Region
12.1.1 Global Haemophilus Influenzae Type B Vaccine Forecast by Region (2026-2031)
12.1.2 Global Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Haemophilus Influenzae Type B Vaccine Forecast by Type (2026-2031)
12.7 Global Haemophilus Influenzae Type B Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Takeda Pharmaceuticals Company
13.5.1 Takeda Pharmaceuticals Company Company Information
13.5.2 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Takeda Pharmaceuticals Company Main Business Overview
13.5.5 Takeda Pharmaceuticals Company Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Lanzhou Institute of Biologica
13.7.1 Lanzhou Institute of Biologica Company Information
13.7.2 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lanzhou Institute of Biologica Main Business Overview
13.7.5 Lanzhou Institute of Biologica Latest Developments
13.8 Immunize BC
13.8.1 Immunize BC Company Information
13.8.2 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
13.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Immunize BC Main Business Overview
13.8.5 Immunize BC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Monovalent HIB
Table 4. Major Players of Liquid Combination HIB
Table 5. Major Players of Lyophilized Monovalent HIB
Table 6. Major Players of Lyophilized Combination HIB
Table 7. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Table 9. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2020-2025)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 12. Global Haemophilus Influenzae Type B Vaccine Sale by Application (2020-2025) & (M Doses)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2020-2025)
Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2020-2025)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2020-2025) & (M Doses)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Haemophilus Influenzae Type B Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 22. Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution and Sales Area
Table 23. Players Haemophilus Influenzae Type B Vaccine Products Offered
Table 24. Haemophilus Influenzae Type B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Haemophilus Influenzae Type B Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 32. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 36. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 39. Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 40. APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2020-2025) & (M Doses)
Table 41. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 44. APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 46. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 48. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 49. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 50. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 52. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 53. Key Market Drivers & Growth Opportunities of Haemophilus Influenzae Type B Vaccine
Table 54. Key Market Challenges & Risks of Haemophilus Influenzae Type B Vaccine
Table 55. Key Industry Trends of Haemophilus Influenzae Type B Vaccine
Table 56. Haemophilus Influenzae Type B Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Haemophilus Influenzae Type B Vaccine Distributors List
Table 59. Haemophilus Influenzae Type B Vaccine Customer List
Table 60. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 61. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 63. Americas Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 65. APAC Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 67. Europe Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 69. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2026-2031) & (M Doses)
Table 71. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2026-2031) & (M Doses)
Table 73. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Novartis Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 76. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Merck Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 81. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Sanofi Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 86. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. GlaxoSmithKline Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 91. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. Takeda Pharmaceuticals Company Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 96. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. Takeda Pharmaceuticals Company Main Business
Table 98. Takeda Pharmaceuticals Company Latest Developments
Table 99. Walvax Biotechnology Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 101. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Walvax Biotechnology Main Business
Table 103. Walvax Biotechnology Latest Developments
Table 104. Lanzhou Institute of Biologica Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 106. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 107. Lanzhou Institute of Biologica Main Business
Table 108. Lanzhou Institute of Biologica Latest Developments
Table 109. Immunize BC Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 111. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 112. Immunize BC Main Business
Table 113. Immunize BC Latest Developments
Table 1. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Haemophilus Influenzae Type B Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Monovalent HIB
Table 4. Major Players of Liquid Combination HIB
Table 5. Major Players of Lyophilized Monovalent HIB
Table 6. Major Players of Lyophilized Combination HIB
Table 7. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Table 9. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2020-2025)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 12. Global Haemophilus Influenzae Type B Vaccine Sale by Application (2020-2025) & (M Doses)
Table 13. Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2020-2025)
Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2020-2025)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2020-2025) & (M Doses)
Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Haemophilus Influenzae Type B Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 22. Key Manufacturers Haemophilus Influenzae Type B Vaccine Producing Area Distribution and Sales Area
Table 23. Players Haemophilus Influenzae Type B Vaccine Products Offered
Table 24. Haemophilus Influenzae Type B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Haemophilus Influenzae Type B Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Haemophilus Influenzae Type B Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 32. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 36. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 39. Americas Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 40. APAC Haemophilus Influenzae Type B Vaccine Sales by Region (2020-2025) & (M Doses)
Table 41. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Haemophilus Influenzae Type B Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 44. APAC Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 45. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 46. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 48. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 49. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2020-2025) & (M Doses)
Table 50. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2020-2025) & (M Doses)
Table 52. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2020-2025) & (M Doses)
Table 53. Key Market Drivers & Growth Opportunities of Haemophilus Influenzae Type B Vaccine
Table 54. Key Market Challenges & Risks of Haemophilus Influenzae Type B Vaccine
Table 55. Key Industry Trends of Haemophilus Influenzae Type B Vaccine
Table 56. Haemophilus Influenzae Type B Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Haemophilus Influenzae Type B Vaccine Distributors List
Table 59. Haemophilus Influenzae Type B Vaccine Customer List
Table 60. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 61. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 63. Americas Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 65. APAC Haemophilus Influenzae Type B Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 67. Europe Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2026-2031) & (M Doses)
Table 69. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2026-2031) & (M Doses)
Table 71. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2026-2031) & (M Doses)
Table 73. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Novartis Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 76. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Merck Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 81. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Sanofi Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 86. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. GlaxoSmithKline Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 91. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. GlaxoSmithKline Main Business
Table 93. GlaxoSmithKline Latest Developments
Table 94. Takeda Pharmaceuticals Company Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 96. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. Takeda Pharmaceuticals Company Main Business
Table 98. Takeda Pharmaceuticals Company Latest Developments
Table 99. Walvax Biotechnology Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 101. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Walvax Biotechnology Main Business
Table 103. Walvax Biotechnology Latest Developments
Table 104. Lanzhou Institute of Biologica Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 106. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 107. Lanzhou Institute of Biologica Main Business
Table 108. Lanzhou Institute of Biologica Latest Developments
Table 109. Immunize BC Basic Information, Haemophilus Influenzae Type B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolios and Specifications
Table 111. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 112. Immunize BC Main Business
Table 113. Immunize BC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Haemophilus Influenzae Type B Vaccine
Figure 2. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid Monovalent HIB
Figure 12. Product Picture of Liquid Combination HIB
Figure 13. Product Picture of Lyophilized Monovalent HIB
Figure 14. Product Picture of Lyophilized Combination HIB
Figure 15. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2025
Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2020-2025)
Figure 17. Haemophilus Influenzae Type B Vaccine Consumed in Hospital
Figure 18. Global Haemophilus Influenzae Type B Vaccine Market: Hospital (2020-2025) & (M Doses)
Figure 19. Haemophilus Influenzae Type B Vaccine Consumed in Research Institutions
Figure 20. Global Haemophilus Influenzae Type B Vaccine Market: Research Institutions (2020-2025) & (M Doses)
Figure 21. Haemophilus Influenzae Type B Vaccine Consumed in Pharmaceutical and Biotechnology Companies
Figure 22. Global Haemophilus Influenzae Type B Vaccine Market: Pharmaceutical and Biotechnology Companies (2020-2025) & (M Doses)
Figure 23. Haemophilus Influenzae Type B Vaccine Consumed in Academic Institutions
Figure 24. Global Haemophilus Influenzae Type B Vaccine Market: Academic Institutions (2020-2025) & (M Doses)
Figure 25. Haemophilus Influenzae Type B Vaccine Consumed in Other
Figure 26. Global Haemophilus Influenzae Type B Vaccine Market: Other (2020-2025) & (M Doses)
Figure 27. Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2024)
Figure 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2025
Figure 29. Haemophilus Influenzae Type B Vaccine Sales by Company in 2025 (M Doses)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2025
Figure 31. Haemophilus Influenzae Type B Vaccine Revenue by Company in 2025 ($ millions)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company in 2025
Figure 33. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 36. Americas Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 37. APAC Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 38. APAC Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Europe Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 40. Europe Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 42. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 43. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2025
Figure 44. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 47. United States Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2025
Figure 52. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 54. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 55. China Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2025
Figure 63. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine in 2025
Figure 80. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 81. Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
Figure 82. Channels of Distribution
Figure 83. Global Haemophilus Influenzae Type B Vaccine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Haemophilus Influenzae Type B Vaccine
Figure 2. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Haemophilus Influenzae Type B Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Haemophilus Influenzae Type B Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Haemophilus Influenzae Type B Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid Monovalent HIB
Figure 12. Product Picture of Liquid Combination HIB
Figure 13. Product Picture of Lyophilized Monovalent HIB
Figure 14. Product Picture of Lyophilized Combination HIB
Figure 15. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2025
Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2020-2025)
Figure 17. Haemophilus Influenzae Type B Vaccine Consumed in Hospital
Figure 18. Global Haemophilus Influenzae Type B Vaccine Market: Hospital (2020-2025) & (M Doses)
Figure 19. Haemophilus Influenzae Type B Vaccine Consumed in Research Institutions
Figure 20. Global Haemophilus Influenzae Type B Vaccine Market: Research Institutions (2020-2025) & (M Doses)
Figure 21. Haemophilus Influenzae Type B Vaccine Consumed in Pharmaceutical and Biotechnology Companies
Figure 22. Global Haemophilus Influenzae Type B Vaccine Market: Pharmaceutical and Biotechnology Companies (2020-2025) & (M Doses)
Figure 23. Haemophilus Influenzae Type B Vaccine Consumed in Academic Institutions
Figure 24. Global Haemophilus Influenzae Type B Vaccine Market: Academic Institutions (2020-2025) & (M Doses)
Figure 25. Haemophilus Influenzae Type B Vaccine Consumed in Other
Figure 26. Global Haemophilus Influenzae Type B Vaccine Market: Other (2020-2025) & (M Doses)
Figure 27. Global Haemophilus Influenzae Type B Vaccine Sale Market Share by Application (2024)
Figure 28. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application in 2025
Figure 29. Haemophilus Influenzae Type B Vaccine Sales by Company in 2025 (M Doses)
Figure 30. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Company in 2025
Figure 31. Haemophilus Influenzae Type B Vaccine Revenue by Company in 2025 ($ millions)
Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company in 2025
Figure 33. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 36. Americas Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 37. APAC Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 38. APAC Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Europe Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 40. Europe Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales 2020-2025 (M Doses)
Figure 42. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue 2020-2025 ($ millions)
Figure 43. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2025
Figure 44. Americas Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Americas Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 47. United States Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2025
Figure 52. APAC Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 54. APAC Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 55. China Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country in 2025
Figure 63. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Haemophilus Influenzae Type B Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type B Vaccine in 2025
Figure 80. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 81. Industry Chain Structure of Haemophilus Influenzae Type B Vaccine
Figure 82. Channels of Distribution
Figure 83. Global Haemophilus Influenzae Type B Vaccine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Hemodialysis Vascular Grafts Market Growth 2024-2030
US$ 3,660.00
March 2024
112 pages
Global Lunasin Market Growth 2025-2031
US$ 3,660.00
December 2025
95 pages
